TATVA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Tatva Chintan Pharma Chem Ltd

Watchlist Manager

Watchlist

Price: 1 659.6 INR -11.82% Market Closed

Market Cap: ₹38.8B

	Tatva Chintan Pharma Chem Ltd BSE:543321	IN
C	Central Japan Railway Co F:JAP	JP
	Fuelcell Energy Inc NASDAQ:FCEL	US
	Isonics Corp OTC:ISON	US
A	Automatic Data Processing Inc XMUN:ADP	US
	Intense Technologies Ltd NSE:INTENTECH	IN

Profitability Summary

Tatva Chintan Pharma Chem Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Sustainable 3Y Average Gross Margin

49%

Gross Margin is Increasing

48% > 57%

Healthy Operating Margin

13%

Low 3Y Average Operating Margin

Declining Operating Margin

13% > 13%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

10% > 9%

Negative Free Cash Flow Margin

-15%

Negative 3Y Average Free Cash Flow Margin

-14%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.